478 related articles for article (PubMed ID: 23927571)
1. Envelope protein gene based molecular characterization of Japanese encephalitis virus clinical isolates from West Bengal, India: a comparative approach with respect to SA14-14-2 live attenuated vaccine strain.
Sarkar A; Banik A; Pathak BK; Mukhopadhyay SK; Chatterjee S
BMC Infect Dis; 2013 Aug; 13():368. PubMed ID: 23927571
[TBL] [Abstract][Full Text] [Related]
2. Molecular evidence for the occurrence of Japanese encephalitis virus genotype I and III infection associated with acute encephalitis in patients of West Bengal, India, 2010.
Sarkar A; Taraphdar D; Mukhopadhyay SK; Chakrabarti S; Chatterjee S
Virol J; 2012 Nov; 9():271. PubMed ID: 23153306
[TBL] [Abstract][Full Text] [Related]
3. A molecularly cloned, live-attenuated japanese encephalitis vaccine SA14-14-2 virus: a conserved single amino acid in the ij Hairpin of the Viral E glycoprotein determines neurovirulence in mice.
Yun SI; Song BH; Kim JK; Yun GN; Lee EY; Li L; Kuhn RJ; Rossmann MG; Morrey JD; Lee YM
PLoS Pathog; 2014 Jul; 10(7):e1004290. PubMed ID: 25077483
[TBL] [Abstract][Full Text] [Related]
4. Sero-Molecular Epidemiology of Japanese Encephalitis in Zhejiang, an Eastern Province of China.
Pan JR; Yan JY; Zhou JY; Tang XW; He HQ; Xie RH; Mao HY; Zhang YJ; Xie SY
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004936. PubMed ID: 27560360
[TBL] [Abstract][Full Text] [Related]
5. Genotype-specific neutralization determinants in envelope protein: implications for the improvement of Japanese encephalitis vaccine.
Ye Q; Xu YP; Zhang Y; Li XF; Wang HJ; Liu ZY; Li SH; Liu L; Zhao H; Nian QG; Deng YQ; Qin ED; Qin CF
J Gen Virol; 2015 Aug; 96(8):2165-2175. PubMed ID: 25908779
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE).
Arroyo J; Guirakhoo F; Fenner S; Zhang ZX; Monath TP; Chambers TJ
J Virol; 2001 Jan; 75(2):934-42. PubMed ID: 11134306
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the live-attenuated Japanese encephalitis vaccine SA14-14-2 strain with its pre-attenuated virulent parent SA14 strain: similarities and differences in vitro and in vivo.
Yun SI; Song BH; Polejaeva IA; Davies CJ; White KL; Lee YM
J Gen Virol; 2016 Oct; 97(10):2575-2591. PubMed ID: 27498826
[TBL] [Abstract][Full Text] [Related]
8. Insight into SNPs and epitopes of E protein of newly emerged genotype-I isolates of JEV from Midnapur, West Bengal, India.
Banerjee S; Sen Gupta PS; Bandyopadhyay AK
BMC Immunol; 2017 Mar; 18(1):13. PubMed ID: 28264652
[TBL] [Abstract][Full Text] [Related]
9. Japanese encephalitis associated acute encephalitis syndrome cases in West Bengal, India: A sero-molecular evaluation in relation to clinico-pathological spectrum.
Sarkar A; Datta S; Pathak BK; Mukhopadhyay SK; Chatterjee S
J Med Virol; 2015 Aug; 87(8):1258-67. PubMed ID: 25939919
[TBL] [Abstract][Full Text] [Related]
10. Molecular epidemiology of Japanese encephalitis in northern Vietnam, 1964-2011: genotype replacement.
Do LP; Bui TM; Hasebe F; Morita K; Phan NT
Virol J; 2015 Apr; 12():51. PubMed ID: 25889499
[TBL] [Abstract][Full Text] [Related]
11. A novel amino acid site closely associated with the neurovirulence of live, attenuated Japanese encephalitis vaccine (SA14-14-2 strain).
Yang H; Fan F; Liu L; Liu J; Sun Y; Xie A; Shi X; Liu L; Yu Y; Li Y; Ge Y; Zeng X; Yang H
Vaccine; 2020 Mar; 38(11):2636-2642. PubMed ID: 32044162
[TBL] [Abstract][Full Text] [Related]
12. Partial cross-protection between Japanese encephalitis virus genotype I and III in mice.
Wei J; Wang X; Zhang J; Guo S; Pang L; Shi K; Liu K; Shao D; Qiu Y; Liu L; Widén F; Li B; Ma Z
PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007601. PubMed ID: 31374086
[TBL] [Abstract][Full Text] [Related]
13. Dynamics of the emergence and establishment of a newly dominant genotype of Japanese encephalitis virus throughout Asia.
Schuh AJ; Ward MJ; Leigh Brown AJ; Barrett AD
J Virol; 2014 Apr; 88(8):4522-32. PubMed ID: 24501419
[TBL] [Abstract][Full Text] [Related]
14. Construction and immune efficacy of recombinant pseudorabies virus expressing PrM-E proteins of Japanese encephalitis virus genotype І.
Qian P; Zhi X; Wang B; Zhang H; Chen H; Li X
Virol J; 2015 Dec; 12():214. PubMed ID: 26651827
[TBL] [Abstract][Full Text] [Related]
15. Study on the protective efficacy of SA14-14-2 attenuated Japanese encephalitis against different JE virus isolates circulating in China.
Liu X; Yu Y; Li M; Liang G; Wang H; Jia L; Dong G
Vaccine; 2011 Mar; 29(11):2127-30. PubMed ID: 21237278
[TBL] [Abstract][Full Text] [Related]
16. Low Protective Efficacy of the Current Japanese Encephalitis Vaccine against the Emerging Genotype 5 Japanese Encephalitis Virus.
Cao L; Fu S; Gao X; Li M; Cui S; Li X; Cao Y; Lei W; Lu Z; He Y; Wang H; Yan J; Gao GF; Liang G
PLoS Negl Trop Dis; 2016 May; 10(5):e0004686. PubMed ID: 27139722
[TBL] [Abstract][Full Text] [Related]
17. Enhanced cytopathic effect of Japanese encephalitis virus strain SA14-14-2: Probable association of mutation in amino acid of its envelope protein.
Nath B; Gupta A; Khan SA; Kumar S
Microb Pathog; 2017 Oct; 111():187-192. PubMed ID: 28867626
[TBL] [Abstract][Full Text] [Related]
18. Genetic Determinants of Japanese Encephalitis Virus Vaccine Strain SA14-14-2 That Govern Attenuation of Virulence in Mice.
Gromowski GD; Firestone CY; Whitehead SS
J Virol; 2015 Jun; 89(12):6328-37. PubMed ID: 25855730
[TBL] [Abstract][Full Text] [Related]
19. Complete genome sequence of two genotype III Japanese encephalitis virus isolates from West Bengal, India.
Taraphdar D; Chatterjee S
Indian J Med Res; 2015 Jul; 142(1):72-8. PubMed ID: 26261169
[TBL] [Abstract][Full Text] [Related]
20. Reduced neutralizing antibody titer against genotype I virus in swine immunized with a live-attenuated genotype III Japanese encephalitis virus vaccine.
Fan YC; Chen JM; Chen YY; Lin JW; Chiou SS
Vet Microbiol; 2013 May; 163(3-4):248-56. PubMed ID: 23415032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
